Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin.

BMC research notes - 2 Jul 2020

Tchiakpe Edmond, Keke Rene K, Vidal Nicole, Ahoussinou Clément, Sekpe Olga, Dagba Hermione G, Gbaguidi Eric, Tonoukouen Conrad, Afangnihoun Aldric, Bachabi Moussa, Gangbo Flore A, Diop-Ndiaye Halimatou, Toure-Kane Coumba

Abstract excerpt

OBJECTIVE: Seventeen years after the start of the IBAARV (Beninese initiative for access to antiretrovirals), transmitted drug resistance mutations in ARV-naïve patients and HIV-1 genetic diversity were investigated in Benin. RESULTS: Drug resistance mutations were detected in (27/248; 10.9%) according to the WHO SDRM 2009 list, with a predominance of mutations directed against NNRTIs drugs (24/248; 10%)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Phylogeny

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 32616057
DOI: 10.1186/s13104-020-05151-w
PMCID: PMC7330984

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin.PMID 32616057Read ↗

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin.Semantic proximity Read ↗

Alarming rate of transmitted drug resistance mutations and genetic diversity in newly HIV-1-infected patients in BeninSemantic proximity Read ↗

HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa.Semantic proximity Read ↗

Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options.Semantic proximity Read ↗

Long-Term Effectiveness of combination Antiretroviral Therapy and Drug Resistance Patterns Among People living with HIV in Benghazi, Libya: Retrospective cohort Study (2009 – 2014)Semantic proximity Read ↗

Genetic variability of HIV type 1 in Bénin.Semantic proximity Read ↗

Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.Semantic proximity Read ↗

HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria.Semantic proximity Read ↗

Predominance of CRF06_cpx and Transmitted HIV Resistance in Algeria: Update 2013-2014.Semantic proximity Read ↗

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.